
SymBiosis
North America, Arkansas, United States, Bentonville
Description
SymBiosis is a venture capital firm.
Investor Profile
SymBiosis has backed more than 12 startups, with 6 new investments in the last 12 months alone. The firm has led 4 rounds, about 33% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B, Series E rounds (top funding stages).
- Majority of deals are located in United States, Australia, Canada.
- Strong thematic focus on Biotechnology, Health Care, Life Science.
- Led 2 rounds in the past year.
Stage Focus
- Series C (42%)
- Series B (25%)
- Series E (17%)
- Series Unknown (17%)
Country Focus
- United States (75%)
- Australia (8%)
- Canada (8%)
- France (8%)
Industry Focus
- Biotechnology
- Health Care
- Life Science
- Pharmaceutical
- Therapeutics
- Biopharma
- Medical
- Clinical Trials
- Oncology
- Precision Medicine
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.